Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking PalsyJosé Á. Obeso, A. Jon Stoessl, María Stamelou et al.|Movement Disorders|2017Cited by 846
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerationsBenjamin Dehay, Wassilios G. Meissner, Andrew Singleton et al.|The Lancet Neurology|2015Cited by 508
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's diseaseMatthieu F. Bastide, Erwan Bézard, Wassilios G. Meissner et al.|Progress in Neurobiology|2015Cited by 472
Priorities in Parkinson's disease researchWassilios G. Meissner, Erwan Bézard, Mark Frasier et al.|Nature Reviews Drug Discovery|2011Cited by 430
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor functionErwan Bézard, Pierre Sokoloff, Sandrine Ferry et al.|Nature Medicine|2003Cited by 381